PDF(389 KB)
Analysis on association between serum homocysteine and inflammatory response and oxidative stress in patients with acute ischemic stroke
Jing TANG,Huan LI,Shuo ZHANG,Ligang JING
PDF(389 KB)
PDF(389 KB)
Analysis on association between serum homocysteine and inflammatory response and oxidative stress in patients with acute ischemic stroke
Objective To discuss the correlation between homocysteine (Hcy) and inflammatory responses as well as oxidative stress, and to analyze its role in the occurrence and development of acute ischemic stroke (AIS). Methods Thirty-eight patients with their first incidence of AIS were selected as AIS group, and according to the principles of case-control study, 45 healthy individuals undergwent routine health examination during the same period were selected as control group. The levels of homocysteine and inflammatory cytokine interleukin (IL)-6, and tumor necrosis factor α (TNF-α) in serum of the subjects in two groups were detected by enzyme-linked immunosorbent assay (ELISA) method; the level of highly sensitive C-reactive protein (hs-CRP) of the subjects in two groups was detected by immunoturbidimetry; the levels of malondialdehyde (MDA) and activities of superoxide dismutase (SOD) in serum of the subjects in two groups were detected by chemical colorimetry; Pearson’s correlation analysis was used to analyze the correlation between serum Hcy level and levels of inflammatory markers and oxidative stress indicators of the AIS patients. Results Compared with control group, the levels of Hcy, hs-CRP, TNF-α, IL-6, and MDA in serum of the patients in AIS group were significantly increased (P<0.05), while the activity of SOD was significantly decreased (P<0.05). The level of Hcy in serum of the AIS patients was positively correlated with the levels of hs-CRP, TNF-α, IL-6, and MDA (r=0.615, P<0.05; r=0.632, P<0.05; r=0.598, P<0.05; r=0.612, P<0.05), and negatively correlated with the activity of SOD (r=-0.325, P<0.05). Conclusion The Hcy level in serum of the AIS patients is closely associated with the inflammatory factors and oxidative damage. Hcy can promote the production of oxidative free radicals and inflammatory factors and cause damage to the endothelial cells and play a significant clinical role in the occurrence and development of AIS.
Acute ischemic stroke / Homocysteine / Inflammatory cytokines / Oxidative stress / Interleukin-6
R743.3
| 1 | CHEN S F, WU P, ZHOU L, et al. Relationship between increase of serum homocysteine caused by smoking and oxidative damage in elderly patients with cardiovascular disease[J]. Int J Clin Exp Med, 2015, 8(3): 4446-4454. |
| 2 | ELSHERBINY N M, SHARMA I, KIRA D, et al. Homocysteine induces inflammation in retina and brain[J]. Biomolecules, 2020, 10(3): 393. |
| 3 | REHMAN T, SHABBIR M A, INAM-UR-RAHEEM M, et al. Cysteine and homocysteine as biomarker of various diseases[J]. Food Sci Nutr, 2020, 8(9): 4696-4707. |
| 4 | SCHERER E B S, LOUREIRO S O, VUADEN F C, et al. Mild hyperhomocysteinemia increases brain acetylcholinesterase and proinflammatory cytokine levels in different tissues[J]. Mol Neurobiol, 2014, 50(2): 589-596. |
| 5 | LAKHAN S E, KIRCHGESSNER A, HOFER M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches[J]. J Transl Med, 2009, 7: 97. |
| 6 | 付洪伟. 缺血性脑血管病病人血清胱抑素C、MMP-9及Hcy水平与颈动脉粥样硬化斑块的相关性分析[J]. 中西医结合心脑血管病杂志, 2019, 17(1): 143-145. |
| 7 | BOEHME A K, ESENWA C, ELKIND M S V. Stroke risk factors, genetics, and prevention[J]. Circ Res, 2017, 120(3): 472-495. |
| 8 | TSIVGOULIS G, PATOUSI A, PIKILIDOU M, et al. Stroke incidence and outcomes in northeastern Greece: the evros stroke registry[J]. Stroke, 2018, 49(2): 288-295. |
| 9 | TU W J, ZHAO Z P, YIN P, et al. Estimated burden of stroke in China in 2020[J]. JAMA Netw Open, 2023, 6(3): e231455. |
| 10 | 鞠吉静, 吴明薪. 脑血管病患者血浆同型半胱氨酸水平分析[J]. 中国城乡企业卫生, 2020, 35(6): 133-134. |
| 11 | WANG M Y, LIANG X S, CHENG M, et al. Homocysteine enhances neural stem cell autophagy in in vivo and in vitro model of ischemic stroke[J]. Cell Death Dis, 2019, 10(8): 561. |
| 12 | WU X Y, ZHOU Q G, CHEN Q, et al. Association of homocysteine level with risk of stroke: a dose-response meta-analysis of prospective cohort studies[J]. Nutr Metab Cardiovasc Dis, 2020, 30(11): 1861-1869. |
| 13 | TU W J, CHAO B H, MA L, et al. Case-fatality, disability and recurrence rates after first-ever stroke: a study from bigdata observatory platform for stroke of China[J]. Brain Res Bull, 2021, 175: 130-135. |
| 14 | SEKERDAG E, SOLAROGLU I, GURSOY-OZDEMIR Y. Cell death mechanisms in stroke and novel molecular and cellular treatment options[J]. Curr Neuropharmacol, 2018, 16(9): 1396-1415. |
| 15 | WU L Q, XIONG X X, WU X M, et al. Targeting oxidative stress and inflammation to prevent ischemia-reperfusion injury[J]. Front Mol Neurosci, 2020, 13: 28. |
| 16 | 刘 洁, 胡小辉, 龚道恺. 急性脑梗死患者外周血Th17、Treg、Th17/Treg 及炎症因子的动态变化过程研究[J]. 临床神经病学杂志, 2020, 33(2): 102-105. |
| 17 | SABIR RASHID A, HUANG-LINK Y, JOHNSSON M, et al. Predictors of early neurological deterioration and functional outcome in acute ischemic stroke: the importance of large artery disease, hyperglycemia and inflammatory blood biomarkers[J]. Neuropsychiatr Dis Treat, 2022, 18: 1993-2002. |
| 18 | MOBARRA N, MOROVATDAR N, NAPOLI M D, et al. The association between inflammatory markers in the acute phase of stroke and long-term stroke outcomes: evidence from a population-based study of stroke[J]. Neuroepidemiology, 2019, 53(1/2): 20-26. |
| 19 | MENGOZZI M, KIRKHAM F A, GIRDWOOD E E R, et al. C-reactive protein predicts further ischemic events in patients with transient ischemic attack or lacunar stroke[J]. Front Immunol, 2020, 11: 1403. |
| 20 | YE Z S, ZHANG H, SUN L L, et al. GWAS-supported CRP gene polymorphisms and functional outcome of large artery atherosclerotic stroke in Han Chinese[J]. Neuromolecular Med, 2018, 20(2): 225-232. |
| 21 | 关 婷, 王思思. 银杏内酯注射液对高危非致残性缺血性脑卒中患者炎性因子水平及神经功能缺损的影响[J]. 现代中西医结合杂志, 2019, 28(16): 1784-1787. |
| 22 | KAMAL F Z, LEFTER R, JABER H, et al. The role of potential oxidative biomarkers in the prognosis of acute ischemic stroke and the exploration of antioxidants as possible preventive and treatment options[J]. Int J Mol Sci, 2023, 24(7): 6389. |
| 23 | DARROUDI S, TAJBAKHSH A, ESMAILY H, et al. 50?bp deletion in promoter superoxide dismutase 1 gene and increasing risk of cardiovascular disease in Mashhad stroke and heart atherosclerotic disorder cohort study[J]. Biofactors, 2020, 46(1): 55-63. |
| 24 | GIBSON M S, DOMINGUES N, VIEIRA O V. Lipid and non-lipid factors affecting macrophage dysfunction and inflammation in atherosclerosis[J]. Front Physiol, 2018, 9: 654. |
/
| 〈 |
|
〉 |